Samia Esmat, MD
Targeting Innate & Adaptive Immunity as a Therapeutic Approach
Interview and audience Q&A
Entries by Ethan Jonke
Yvon Gauthier, MD
Segmental Vitiligo Pattern and Cutaneous Arterial Vessel Mapping: An Anatomoclinical and Physiopathological Approach
Iltefat Hamzavi, MD
Outlining Vitiligo: Overview, Epidemiology & Burden of Disease
Interview and audience Q&A
Pfizer Satellite Meeting
Pfizer Satellite Meeting
Vitiligo Talks: Understanding the Burden of Disease & Pathophysiology
Panel discussion and audience Q&A
Amit G. Pandya, MD
Invited Speaker: Update on Jak Inhibitors For Vitiligo
Abburi Ramaiah, PhD
Combinatorial Therapies With Basic Fibroblast Growth Factor Related Agonist Peptides to Treat Vitiligo
Thierry Passeron, MD, PhD
Effect of Ruxolitinib Cream on Achievement of VASI50 by Body Region: Week 52 Pooled Analysis of the TRuE-V Phase 3 Studies
Rania Mogawer, MBBch, MSc, MD
Effect of Narrow Band Ultraviolet B on the Tissue Level of Interleukin 15 and Interleukin 15 Receptor Alpha Subunit in Active Non Segmental Vitiligo Cases: An Interventional Cohort Study
Vidhya Narayan, MD
NB-UVB Phototherapy Response of Different Body Regions in Non-segmental Vitiligo
Marwa Abdallah, MD
Azathioprine Monotherapy vs Azathioprine-NB-UVB vs OMP-NB-UVB in Controlling Active Vitiligo, A Randomized, Controlled Study
